Capacity Building Briefing

Overview of Pharmacovigilance National

Program:
Activities Developed During the COVID-
19 Pandemic

Date September 21 & 23, 2022

2:30 p.m. - 4:00 p.m.

Introducing the Lebanese National Pharmacovigilance

Objectives Program (LNPVP)
Sharing the LNPVP's objectives, implementation steps
and role in the context of COVID-19 vaccines

Target Pharmacists and patient safety advocates from the

Lebanese healthcare community
Audience 82 participants

Pr. Rita Karam

Speakers Dr. Abeer Zeitoun
Dr. Carla Allam

Topics Presented Take Home Messages

1. Overview of Pharmacovigilance: 1. Involvement of patients, healthcare
Establishment and Operations professionals, and pharmaceutical
companies in the pharmacovigilance
process is fundamental
2. Pharmacovigilance General
Operations with Emphasis on Adverse
Events Following Immunization The LNPVP's regular report on the COVID-
2.
Reporting Means 19 safety profile presents data related to
means of reporting, received dose
Overview of the Safety Profile of numbers, geographical location, and
3. COVID-19 Vaccines: February 14th, seriousness criteria
2021 – August 30th, 2022
3. Patients are encouraged to report AEFIs
Evaluation of the COVID-19 through the Med Safety App

4. Vaccination Process in Lebanon: A

National Descriptive Study 4. Regular assessment of the Lebanese
vaccination centers should be conducted
to ensure compliance with national and
international standards

Lebanese National Pharmacovigilance Program; Quality Assurance of

Pharmaceutical Products Program | Ministry of Public Health